Hamid, O.; Lewis, K.; Weise, A.; McKean, M.; Papadopoulos, K. P.; Crown, J.; Kim, T. M.; Lakhani, N. J.; Kaczmar, J.; Kudchadkar, R.; Spira, A.; Rabinowits, G.; Kim, K.; Carvajal, R.; Williamson, S.; Ioffe, E.; Chen, S.; Mani, J.; Jankovic, V.; Brennan, L.; Kroog, G.; Sims, T.; Lowy, I.; Gullo, G. Phase 1 Study of Fianlimab, a Human Lymphocyte Activation Gene-3 Monoclonal Antibody, in Combination With Cemiplimab in Advanced Melanoma: Expansion Cohort Analysis. J of Skin 2023, 7, s179.